Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001683168-23-005299
Filing Date
2023-08-04
Accepted
2023-08-04 16:40:53
Documents
7

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 pharmacyte_s3a1.htm S-3/A 219139
2 OPINION pharmacyte_ex0501.htm EX-5.1 12483
3 CONSENT pharmacyte_ex2301.htm EX-23.1 5282
4 CALCULATION OF FILING FEE TABLES pharmacyte_ex107.htm EX-FILING FEES 11390
5 GRAPHIC m1.jpg GRAPHIC 9984
6 GRAPHIC image_002.jpg GRAPHIC 2373
7 GRAPHIC image_001.jpg GRAPHIC 2248
  Complete submission text file 0001683168-23-005299.txt   269993
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: S-3/A | Act: 33 | File No.: 333-272569 | Film No.: 231144584
SIC: 2836 Biological Products, (No Diagnostic Substances)